The importance of vaccines in preventing serious respiratory illness is no secret. But Sanofi’s recent $2.5 billion acquisition of Vicebio also marks a powerful signal of…

Living with more than one chronic condition is now a daily reality for nearly 40 per cent of Australians — and that number is expected to grow.

In a familiar blend of rhetoric and ambiguity, US President Donald Trump has again raised the prospect of imposing sweeping tariffs on foreign-made…

Every human body begins with a single cell. But how that cell divides, specialises and gives rise to the extraordinary complexity of tissues and organs has…

China is once again shifting gears in biotech. Under a new draft policy, the country’s drug regulator is proposing to halve its clinical trial review period for novel medicines—from 60 to just 30 working days.

When it comes to Aboriginal and Torres Strait Islander, progress is happening—but it’s not happening fast. That’s the key message from the latest Aboriginal and Torres Strait Islander Health Performance…

In a ground-breaking initiative, researchers at the Peter Doherty Institute for Infection and Immunity (Doherty Institute), in collaboration with seven major Victorian hospitals, have successfully…

We often hear how overstretched Australia’s hospitals are. But what’s less often said is how many of those hospital stays may not have been necessary…

For all the talk of learning from COVID-19, global action has often lagged behind intent. That’s why the formal adoption of a new pandemic agreement…

Miscarriage is common. But a national clinical guidance on how to care for it? That’s new. For the first time, Australia has a national guideline to support clinical…

As climate disasters become more frequent, it’s not just homes and infrastructure that are being hit repeatedly—it’s people’s mental health too

In workplaces across Australia, millions of employees are silently powering through days marked by debilitating pain…